Stroke Genomics and Exit Strategies
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: 15 October 2024 | Viewed by 245
Special Issue Editors
Interests: stroke genetics; CADASIL; moyamoya disease; RNF213-related vasculopathy; endovascular therapy
Special Issue Information
Dear Colleagues,
The inexorable shift towards personalized medicine, driven by the integration of genomic insights, is shaping the medical landscape. Notably, recent expansive genomic endeavors have unearthed numerous loci intricately linked to strokes, giving rise to the development of polygenic risk models.
Whereas genomic medicine has already found its footing within oncology, driving treatment decisions via genomic analysis, its integration into the realm of stroke management remains an uncharted territory despite these remarkable advancements. Hence, the theme of social implementation emerges as a pivotal pursuit within stroke genomics.
This Special Issue stands as a beacon for publishing cutting-edge research articles and reviews centered explicitly on stroke genomics. We extend a warm invitation to authors to submit their work, particularly those that illuminate exit strategies essential for the integration of genomic medicine in stroke care.
Dr. Hiroyuki Ishiyama
Dr. Tomotaka Tanaka
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stroke genomics
- stroke
- personalized medicine
- precision medicine
- exit strategy
